| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |